Pharmac is proposing to widen access to a medicine used in the treatment of chronic heart failure.
The medicine, empagliflozin, would be available to people who have chronic heart failure with reduced ejection fraction – about half of all people with chronic heart failure.
Pharmac director of pharmaceuticals Geraldine MacGibbon says empagliflozin is a medicine that can give people more time with their loved ones and lessens the time spent in hospital.
ACC has started a one-month public consultation on suggested annual levy rises of more than 7 percent for motorists and a potential 33 percent increase for motorcyclists. AA principal policy advisor Terry Collins spoke to Corin Dann. Read...
A leaked document authored by West Coast Health and marked “Confidential for Te Whatu Ora staff only” proposes that urgent primary care and after hour services will be offered via telehealth rather than by doctors and registered nurses for the entire West Coast...
Health New Zealand has scrapped the highest Code Black alert used by some emergency departments to show when they are critically overcrowded or understaffed. Read...
HEALTH SERVICES AND SYSTEMS
EQUITY
Exploring the impacts of the health system on minorities within the population, notably including Māori, Pacifica, Asians and LGBTQI.
DRUGS, DEVICE AND DIAGNOSTICS
PUBLIC HEALTH
DIGITAL HEALTH
TE TIRITI